Homology Medicines, Inc. (FIXX) NASDAQ
0.93
+0.0071(+0.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.5M |
| Enterprise Value | -25.62M |
| P/E Ratio | 5.36 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 3.01 |
| Price/Book Ratio | 3.85 |
| Enterprise/Revenue | 2.27 |
| Enterprise/EBITDA | 5.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.62 |
| Operating Margin | 0.4 |
Management Effectiveness
| Return On Assets | 0.52 |
| Return On Equity | 2.31 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 3.81 |
| Gross Profit | 0 |
| EBITDA | 16.9M |
| Net Income | 29.82M |
| Diluted EPS | 2.42 |
Balance Sheet
| Total Cash | 50.75M |
| Total Cash/Share | 3.6 |
| Total Debt | 10.99M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 5.36 |
| Book Value Per Share | 3.29 |
Price History
| 52-Week Change | -94.75 |
| 52-Week High | 26.64 |
| 52-Week Low | 0.9 |
| Moving Average 50 Days | 13.8 |
| Moving Average 200 Days | 16.1 |
Statistics
| Average Volume | 29,535 |
| Shares Outstanding | 3.23M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | March 25, 2024 |
